Yen-Michael Sheng Hsu

14PUBLICATIONS
32CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 01, 2026
Same-day rescue plerixafor during leukapheresis is safe and effective in allogeneic donors suboptimally responding to granulocyte colony-stimulating factor mobilization.

|Jul 31, 2026
Characterization of Short Production Cycle and Nongenotoxic mRNA-Based CAR-T Cells Targeting CD19-Positive and CD22-Positive Malignancies.

|Jul 19, 2023
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help.

Kevin J Curran, Sarah Nikiforow, Carlos Bachier

|Feb 10, 2022
How do I: Evaluate the safety and legitimacy of unproven cellular therapies?

Indira Guleria, Maria de Los Angeles Muñiz, Matthew Wilgo

|Jul 29, 2020
Thawed solvent/detergent-treated plasma demonstrates comparable clinical efficacy to thawed plasma.

Sabrina E Racine-Brzostek, Matthew C Canver, Robert A DeSimone

|Jul 29, 2020
Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.

Yogindra Vedvyas, Jaclyn E McCloskey, Yanping Yang

Pageof 3

Frequent Collaborators

6 joint publications

Robert A DeSimone

6 joint publications

Melissa M Cushing

5 joint publications

Ljiljana Vasovic

3 joint publications

Ruchika Goel